ArcticZymes Technologies ASA (DE:B4V) has released an update.
ArcticZymes Technologies ASA has announced Dr. Frank Mathias as the new Chairman of the Board, bringing in his extensive experience in the biopharmaceutical industry, including senior roles at various global companies and recognition as ‘EY Entrepreneur of the Year’ in Germany. His appointment is expected to lead the company into further development, commercialization, and growth, leveraging his successful track record in the industry.
For further insights into DE:B4V stock, check out TipRanks’ Stock Analysis page.
